Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Jul. 31, 2023
Jul. 31, 2022
Reconciliation of net loss to net cash used in operating activities:    
Net loss $ (7,209) $ (10,242)
Stock option compensation to employees and directors 3,265 4,928
Stock options and warrants issued to consultants 175 546
Common stock issued to consultants 67 72
Amortization of operating lease right-of-use asset 34 31
Change in operating assets and liabilities:    
Receivables (288)
Prepaid expenses and other current assets (65) (400)
Accounts payable (171) 91
Accrued expenses (14) 103
Operating lease liability (34) (28)
Net cash used in operating activities (4,240) (4,899)
Cash flows from investing activities:    
Disbursements to acquire short-term investments (27,502) (11,159)
Proceeds from maturities of short-term investments 22,493 10,348
Net cash used in investing activities (5,009) (811)
Cash flows from financing activities:    
Proceeds from sale of common stock pursuant to employee stock purchase plan 6 6
Proceeds from exercise of stock options 81 830
Net cash provided by financing activities 87 836
Net decrease in cash and cash equivalents (9,162) (4,874)
Cash and cash equivalents at beginning of period 12,360 29,128
Cash and cash equivalents at end of period $ 3,198 $ 24,254